Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis

NANot yet recruitingINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

End Stage Renal Disease

Interventions

DEVICE

Hemodialysis or Hemodiafiltration either with sodium zero-diffusive treatment or standard treatment without sodium-control

Patients will be treated for 12 weeks thrice weekly Hemodialysis or Hemodiafiltration sessions resulting in 36 sessions per patient.

All Listed Sponsors

lead

Fresenius Medical Care Deutschland GmbH

INDUSTRY

NCT06341452 - Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis | Biotech Hunter | Biotech Hunter